Ninomiya N, Matsuda I, Matsuoka T, Iwamasa T, Nonaka I
J Neurol Sci. 1984 Nov-Dec;66(2-3):129-39. doi: 10.1016/0022-510x(84)90001-7.
The nature of mutant acid alpha-glucosidase (AAG) in muscle was studied in 6 patients with Pompe disease, consisting of 2 each of the infantile, childhood and adult types. Anti-human liver AAG rabbit antibody prepared in the present study was confirmed to be monospecific by immunodiffusion, immunotitration and immunohistochemical methods. It was found by the immunodiffusion and enzyme immunoassay methods using this antibody that the mutation produced a normal amount of enzyme protein but the latter was an inactive form, suggesting structural gene mutation in 5 of the 6 cases. In the remaining childhood type case there was no detectable amount of enzyme protein, suggesting that the mutation causes a reduction in the amount of the enzyme protein or synthesis of unstable enzyme protein. Similarly, the enzyme activity of AAG was markedly reduced in all patients, but that of neutral alpha-glucosidase was the least reduced in the adult type, medium in the childhood type, and the most reduced in the infantile type.
对6例庞贝病患者肌肉中突变酸性α-葡萄糖苷酶(AAG)的性质进行了研究,其中婴儿型、儿童型和成人型各2例。本研究制备的抗人肝脏AAG兔抗体经免疫扩散、免疫滴定和免疫组织化学方法确认为单特异性。使用该抗体通过免疫扩散和酶免疫测定方法发现,突变产生了正常量的酶蛋白,但后者为无活性形式,提示6例中有5例存在结构基因突变。在其余儿童型病例中,未检测到酶蛋白,提示突变导致酶蛋白量减少或合成不稳定的酶蛋白。同样,所有患者的AAG酶活性均显著降低,但中性α-葡萄糖苷酶活性在成人型中降低最少,在儿童型中居中,在婴儿型中降低最多。